Continuous Process to Safely Manufacture an Aryldiazoacetate and Its Direct Use in a Dirhodium-Catalyzed Enantioselective Cyclopropanation-Reference-Cited by-同舟云学术

Continuous Process to Safely Manufacture an Aryldiazoacetate and Its Direct Use in a Dirhodium-Catalyzed Enantioselective Cyclopropanation

Published:2022-12-14 Issue:1 Volume:27 Page:90-104
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Lathrop Stephen P.¹^ORCID,Mlinar Laurie B.¹,Manjrekar Onkar N.¹,Zhou Yong¹,Harper Kaid C.¹^ORCID,Sacia Eric R.¹,Higgins Molly¹,Bogdan Andrew R.²^ORCID,Wang Zhe¹^ORCID,Richter Steven M.¹^ORCID,Gong Wei³,Voight Eric A.³^ORCID,Henle Jeremy¹^ORCID,Diwan Moiz¹^ORCID,Kallemeyn Jeffrey M.¹^ORCID,Sharland Jack C.⁴,Wei Bo⁴,Davies Huw M. L.⁴^ORCID

Affiliation:

1. Process Research and Development, AbbVie Inc., North Chicago, Illinois60064, United States

2. Advanced Chemistry Technologies, AbbVie Inc., North Chicago, Illinois60064, United States

3. Drug Discovery Science & Technology, AbbVie Inc., North Chicago, Illinois60064, United States

4. Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia30322, United States

Funder

AbbVie

Center for Selective C-H Functionalization, National Science Foundation

National Science Foundation

Publisher

American Chemical Society (ACS)

Subject